Premier Alternatives

Click Therapeutics

New York, NY · Founded 2012 · Privately Held (backing)

Developer of software as a medical treatment prescription platform designed to deliver safe digital treatments to patients in need. Click Therapeutics is based in New York, NY and was founded in 2012. It was valued at $601 million at its later-stage round in Apr 2026, the last priced event on record. It has raised $268 million across 9 recorded rounds; the latest was a $48.6 million early-stage round in Mar 2025.

PMV mark · valuation
$600.5M
Oct 2026
Priced at
its later-stage round
Apr 2026
Total raised
$268.4M
Last round
Early Stage VC
Mar 2025

Click Therapeutics key facts

as of Oct 2026
  • Developer of software as a medical treatment prescription platform designed to deliver safe digital treatments to patients in need.
  • Click Therapeutics is valued at approximately $600.5M as of Oct 2026, set at its later-stage round, Apr 2026; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $268.4M across 9 recorded rounds; the latest was Early Stage VC ($48.6M) in Mar 2025.
  • Notable investors include Revelation Partners, SharesPost, Otsuka Pharmaceutical, Accelmed, Boehringer Ingelheim — 19 tracked in total.
  • Click Therapeutics has filed 9 Form Ds with the SEC since 2014, most recently Apr 2025 ($48.6M sold to 3 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
MEDIUM confidence
$600.5M

Valued at $600.5M at its later-stage round, Apr 2026. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Click Therapeutics with a free account
  • ·The complete investor list: 19 names
  • ·Watch Click Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Click Therapeutics funding rounds

9 rounds
Mar 2025Early Stage VC$48.6MSEC filing▮
Aug 2024Debt$8.3MSEC filing▮
May 2024Seed Round$3.0MSEC filing▮
Oct 2021Later Stage VC$52.1MSEC filing▮
Jun 2018Early Stage VC$17.3MSEC filing▮
Full funding history →

Click Therapeutics valuation

Click Therapeutics was valued at $601 million at its later-stage round in Apr 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Click Therapeutics raised?

Click Therapeutics has raised $268 million across 9 recorded rounds since 2014. The largest was an $8.3 million debt round in Aug 2024; the most recent was a $48.6 million early-stage round in Mar 2025.

Click Therapeutics has filed 9 Form Ds with the SEC since 2014, most recently in Apr 2025 ($48.6 million sold to 3 investors).

Click Therapeutics investors

19 investors are on record for Click Therapeutics, including Revelation Partners, SharesPost, Otsuka Pharmaceutical and Accelmed. The early-stage round in Mar 2025 drew 3 investors.

About Click Therapeutics

Developer of software as a medical treatment prescription platform designed to deliver safe digital treatments to patients in need. The company's platform personalizes user experiences to drive cognitive and behavioral outcomes, enabling the medical community to optimally treat individuals with brain disorders and neuro-psychiatric dysfunctions.

Sector
Healthcare
HQ
New York, NY, United States
Founded
2012
Employees
134
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.